The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trial.
about
Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial.Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data
P2860
The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The haemoglobin glycation inde ...... ations in the AleCardio trial.
@en
type
label
The haemoglobin glycation inde ...... ations in the AleCardio trial.
@en
prefLabel
The haemoglobin glycation inde ...... ations in the AleCardio trial.
@en
P2093
P2860
P356
P1476
The haemoglobin glycation inde ...... ations in the AleCardio trial.
@en
P2093
AleCardio study group
Diederick E Grobbee
Ilse C Schrieks
J Hans DeVries
Jean-Claude Tardif
Joost Bl Hoekstra
Lars Rydén
Linda G Mellbin
Sigrid Cj van Steen
P2860
P304
P356
10.1177/2047487317692664
P577
2017-01-01T00:00:00Z